BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Co.’s infectious disease unit, who came on board when that company acquired infectious disease company Rempex Pharmaceuticals Inc....
BioCentury | Oct 26, 2018
Finance

Rempex remix

...$33 million A round in hope that the management team will repeat its performance at Rempex Pharmaceuticals Inc....
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Co.’s infectious disease unit, who came on board when that company acquired infectious disease company Rempex Pharmaceuticals Inc....
...tranches; details are not disclosed. Assistant Editor Virginia Li contributed to this report. Paul Bonanos Mpex Pharmaceuticals Inc. Rempex Pharmaceuticals Inc. The...
BioCentury | Sep 1, 2017
Clinical News

FDA approves cUTI combo Vabomere from MDCO

...Diego in October. The approval triggers a $40 million milestone payment to former shareholders of Rempex Pharmaceuticals Inc....
BioCentury | Aug 30, 2017
Company News

FDA approves cUTI combo from MDCO

...in San Diego. The approval triggers a $40 million milestone payment to former shareholders of Rempex Pharmaceuticals Inc....
BioCentury | Jan 5, 2015
Finance

Back for more

...firm also counts the 2013 takeouts of cancer company Ceptaris Therapeutics Inc. , antibiotics play Rempex Pharmaceuticals Inc....
BioCentury | Nov 17, 2014
Clinical News

Carbavance: Phase III started

...neutropenia (see BioCentury Jan. 20). The Medicines Co. gained the product through its acquisition of Rempex Pharmaceuticals Inc....
BioCentury | Nov 17, 2014
Clinical News

Carbavance: Phase III started

...neutropenia (see BioCentury Jan. 20). The Medicines Co. acquired the product through its acquisition of Rempex Pharmaceuticals Inc....
BioCentury | Jun 9, 2014
Finance

Banker tracks

...Sciences as venture partners. Burgess founded and was president and CEO of infectious disease company Rempex Pharmaceuticals Inc....
BioCentury | Feb 10, 2014
Company News

Medicines Co., U.S. Department of Health and Human Services (HHS) infectious news

...lactamase inhibitor, and biapenem (RPX2003), a generic carbapenem antibiotic - through its December acquisition of Rempex Pharmaceuticals Inc....
Items per page:
1 - 10 of 26
BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Co.’s infectious disease unit, who came on board when that company acquired infectious disease company Rempex Pharmaceuticals Inc....
BioCentury | Oct 26, 2018
Finance

Rempex remix

...$33 million A round in hope that the management team will repeat its performance at Rempex Pharmaceuticals Inc....
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Co.’s infectious disease unit, who came on board when that company acquired infectious disease company Rempex Pharmaceuticals Inc....
...tranches; details are not disclosed. Assistant Editor Virginia Li contributed to this report. Paul Bonanos Mpex Pharmaceuticals Inc. Rempex Pharmaceuticals Inc. The...
BioCentury | Sep 1, 2017
Clinical News

FDA approves cUTI combo Vabomere from MDCO

...Diego in October. The approval triggers a $40 million milestone payment to former shareholders of Rempex Pharmaceuticals Inc....
BioCentury | Aug 30, 2017
Company News

FDA approves cUTI combo from MDCO

...in San Diego. The approval triggers a $40 million milestone payment to former shareholders of Rempex Pharmaceuticals Inc....
BioCentury | Jan 5, 2015
Finance

Back for more

...firm also counts the 2013 takeouts of cancer company Ceptaris Therapeutics Inc. , antibiotics play Rempex Pharmaceuticals Inc....
BioCentury | Nov 17, 2014
Clinical News

Carbavance: Phase III started

...neutropenia (see BioCentury Jan. 20). The Medicines Co. gained the product through its acquisition of Rempex Pharmaceuticals Inc....
BioCentury | Nov 17, 2014
Clinical News

Carbavance: Phase III started

...neutropenia (see BioCentury Jan. 20). The Medicines Co. acquired the product through its acquisition of Rempex Pharmaceuticals Inc....
BioCentury | Jun 9, 2014
Finance

Banker tracks

...Sciences as venture partners. Burgess founded and was president and CEO of infectious disease company Rempex Pharmaceuticals Inc....
BioCentury | Feb 10, 2014
Company News

Medicines Co., U.S. Department of Health and Human Services (HHS) infectious news

...lactamase inhibitor, and biapenem (RPX2003), a generic carbapenem antibiotic - through its December acquisition of Rempex Pharmaceuticals Inc....
Items per page:
1 - 10 of 26